Cover Image
Market Research Report

Asia Pacific Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Technology ; Application, and Country

Published by The Insight Partners Product code 967102
Published Content info 147 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Technology ; Application, and Country
Published: September 15, 2020 Content info: 147 Pages
Description

Title:
Asia Pacific Liposome Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, and Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, and Photodynamic Therapy), and Country.

The Asia Pacific liposome drug delivery market is expected to reach US$ 1,562.92 million in 2027 from US$ 759.81 in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027.

The growth of the market is attributed to the some key driving factors such as high incidence of chronic diseases amongst the population, an upsurge in need for non-invasive drug delivery solutions, increasing investments in R&D for pharmaceutical companies. However, high expense involved in the development of drug delivery systems is expected to obstruct the growth of the market to a certain extent during the forecast years.

Liposomes are small sphere-shaped artificial vesicles synthesized from cholesterol and phospholipids. They have multiple layers and a diameter range of 0.01 to 5.0 um. They also have hydrophilic and hydrophobic properties which help liposomes to encapsulate hydrophobic and hydrophilic drugs to be delivered to targeted body site. Liposomes provide an assured system for targeted drug delivery and thereby is the factor influencing the Liposome Drug Delivery market size growth. Liposomes are widely used for enclosing all types of drug molecules such as acyclovir, chloroquine diphosphate, paclitaxel, tropicamide, and cyclosporine. Liposomes are used as a drug carrier for drug therapy for many diseases since they are biodegradable and biocompatible. Also, they have many therapeutic properties like anticancer drugs, genetic materials, proteins, vaccines, macromolecules, and thus can be encapsulated in liposomes.

Research and development (R&D) in liposomal drug delivery systems are increasing across the world due to the increasing prevalence of chronic disease. Drug delivery is the process of dispensing a pharmaceutical compound to attain a therapeutic effect in humans. Liposomal drug delivery offers multiple advantages such as better pharmacokinetics and pharmacodynamics, enhanced therapeutic efficacy, and decreased toxicity making these delivery systems ideal for patients suffering from various chronic conditions.

Death among the population worldwide has increased due to cancer. The targeted drug delivery system delivers the drug in a controlled manner at a preselected bio site. Nanotechnology-based delivery systems are making a crucial impact on cancer treatment, and the polymers play a key role in the development of Nano particulate carriers for cancer therapy. Some of the major technological advantages involved in the nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved bio-distribution, increased circulation time of the drug, controlled and sustained release of the drug, versatility of route of administration, increased intercellular concentration of the drug, and many more. The liposomal carriers used in nanotechnology drug delivery systems are likely to experience rapid adoption, which in turn is propelling the market growth.

As per the data provided by, European Society for Medical Oncology, China estimated there were 4.3 million new cancer cases and more than 2.8 million cancer deaths in China in 2015, with lung cancer the most common cancer and the leading cause of cancer death. With high incidences and mortality, cancer is the leading cause of death in China and is a major public health problem. Further, Conference Series LLC Ltd is going to host Pharmaceutics & Novel Drug Delivery Summit China, which is going to be held during November 16-17, 2020, in Shanghai, China, for the adoption of novel drug delivery system. For instance, Lipusu (chemotherapy treatment of certain types of cancer) was the most popular pharmaceutical product for cancer treatment in China in the first half of 2018, as well as the most popular paclitaxel product in China in the first half of 2018 with a market share of approximately 34.8%.

Diabetes is one of the leading life-threatening chronic diseases with no functional cure. As there is a significant increase in diabetes cases across the world, it is resulting in life-changing complications among the population. Exogenous insulin is usually administered through a subcutaneous route of administration for diabetes management. However, the recent attention towards insulin-coated liposomal carriers facilitating oral insulin intake and activating the target drug delivery action, which on the other hand is propelling the growth of the liposome drug delivery market over the coming years.

Based on product, the liposome drug delivery market is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, others. The liposomal doxorubicin segment held the largest share of the market in 2019, whereas the liposomal amphotericin B segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on technology, the liposome drug delivery market has been segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. The stealth liposome technology segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period.

Based on application, the liposome drug delivery market has been segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy. The cancer therapy segment held the largest share of the market in 2019, and continued to register the highest CAGR in the market during the forecast period.

Some of the major primary and secondary sources for liposome drug delivery market included in the report are National Cancer Institute (NCI), Chinese Society of Clinical Oncology (CSCO) Guidelines, and others.

Reasons to Buy:

To understand the Asia Pacific liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return.Stay ahead of the race by comprehending the ever-changing competitive landscape for mammography systems market.

Efficiently plan M&A and partnership deals in Asia Pacific liposome drug delivery market by identifying market segments with the most promising probable sales.

Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific liposome drug delivery market.

Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia Pacific region.

Table of Contents
Product Code: TIPRE00014175

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia PacificLiposome Drug Delivery Market - By Product
    • 1.3.2 Asia PacificLiposome Drug Delivery Market- By Technology
    • 1.3.3 Asia PacificLiposome Drug Delivery Market - By Application
    • 1.3.4 Asia PacificLiposome Drug Delivery Market - By Geography

2. Asia PacificLiposome Drug Delivery Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia PacificLiposome Drug Delivery Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Liposome Drug Delivery Market - Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia PacificLiposome Drug Delivery Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 High Incidence Of Chronic Diseases Amongst the Population
    • 5.1.2 An Upsurge In Need For Non-Invasive Drug Delivery Devices
    • 5.1.3 Increasing Investments In R&D For Pharmaceutical Companies
  • 5.2 Key Market Restraints
    • 5.2.1 High Expense in Development of Drug Delivery Systems
  • 5.3 Key Market Opportunities
    • 5.3.1 New Developments in Lipid Composition for Stability and Optimization of Drugs
  • 5.4 Future Trends
    • 5.4.1 High Rise in Popularity of Liposomes in Drug Delivery
  • 5.5 Impact Analysis

6. Liposome Drug Delivery Market - Asia Pacific Analysis

  • 6.1 Asia PacificLiposome Drug Delivery MarketRevenue Forecasts and Analysis

7. Asia PacificLiposome Drug Delivery Market Analysis and Forecasts To 2027 - By Product

  • 7.1 Overview
  • 7.2 Asia PacificLiposome Drug Delivery Market, By Product 2019& 2027 (%)
  • 7.3 Liposomal Doxorubicin
    • 7.3.1 Overview
    • 7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Liposomal Paclitaxel
    • 7.4.1 Overview
    • 7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Liposomal Amphotericin B
    • 7.5.1 Overview
    • 7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

8. Liposome Drug Delivery Market - By Technology

  • 8.1 Overview
  • 8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • 8.3 Stealth Liposome Technology
    • 8.3.1 Overview
    • 8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Non-PEGylated Liposome Technology
    • 8.4.1 Overview
    • 8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DepoFoam Liposome Technology
    • 8.5.1 Overview
    • 8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
    • 8.6.1 Overview
    • 8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

9. Liposome Drug Delivery Market Analysis - By Application

  • 9.1 Overview
  • 9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • 9.3 Fungal Diseases
    • 9.3.1 Overview
    • 9.3.2 Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Cancer Therapy
    • 9.4.1 Overview
    • 9.4.2 Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Pain Management
    • 9.5.1 Overview
    • 9.5.2 Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.6 Viral Vaccine
    • 9.6.1 Overview
    • 9.6.2 Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.7 Photodynamic Therapy
    • 9.7.1 Overview
    • 9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)

10. Liposome Drug Delivery Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 Asia PacificLiposome Drug Delivery MarketRevenue and Forecasts To 2027
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
    • 10.1.3 Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
    • 10.1.4 Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
    • 10.1.5 Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
    • 10.1.7 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.1 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.2 China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.3 China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.7.4 China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.8 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.1 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.2 Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.3 Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.8.4 Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.9 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.1 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.2 India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.3 India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.9.4 India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.10 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.1 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.2 South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.3 South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.10.4 South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
    • 10.1.11 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.1 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.2 Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.3 Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
      • 10.1.11.4 Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on Asia PacificLiposome Drug Delivery Market

  • 11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Takeda Pharmaceutical Company Limited
  • 12.2 Novartis AG
  • 12.3 Luye Pharma Group
  • 12.4 Johnson & Johnson Services, Inc.
  • 12.5 Astellas Pharma Inc.

13. Appendix

  • 13.1 About the Insight Partners

List Of Tables

  • Table 1. Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 4. China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 6. China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 10. India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 11. India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 12. India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 13. South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 14. South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 15. South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)

List Of Figures

  • Figure 1. Liposome Drug Delivery Market Segmentation
  • Figure 2. Asia PacificLiposome Drug Delivery Market Overview
  • Figure 3. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market
  • Figure 4. Japan Is Expected to Show Highest Market Share During the Forecast Period
  • Figure 5. Liposome Drug Delivery Market - Asia Pacific PEST Analysis
  • Figure 6. Liposome Drug Delivery Market Impact Analysis of Driver and Restraints
  • Figure 7. Asia PacificLiposome Drug Delivery Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 8. Asia PacificLiposome Drug Delivery Market, By Product 2019 & 2027 (%)
  • Figure 9. Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 10. Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 11. Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 12. Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 13. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
  • Figure 14. Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 15. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
  • Figure 19. Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Asia Pacific: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 25. Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
  • Figure 26. Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
  • Figure 27. China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Back to Top